QNRX

Quoin Pharmaceuticals, Ltd. - ADR

3.65

USD

-0.20

-5.19%

Nov 06, 15:59 UTC -5

Closed

After-Market

3.86

+0.21

+5.75%

Quoin Pharmaceuticals, Ltd. - ADR (QNRX) Earnings

QNRX Earnings Reports

Positive Surprise Ratio

QNRX beat 16 of 24 last estimates.

67%

Next Report

Date of Next Report

Mar 24, 2027

Estimate for Q4 26 (Revenue/ EPS)

-$1.51

Implied change from Q3 26 (Revenue/ EPS)

Implied change from Q4 25 (Revenue/ EPS)

+0.67%

Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue

On Nov 04, 2026, QNRX reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -1.64 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.

Looking ahead to Q4 26, -- analysts forecast an EPS of -1.51 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

ZOETIS INC.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.52

Actual

$1.75

Surprise

+14.64%

Amylyx Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.38

Actual

-$0.38

Surprise

+1.04%

Guardian Pharmacy Services, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.30

Actual

$0.33

Surprise

+7.84%

Xeris Biopharma Holdings, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.02

Actual

$0.06

Surprise

+144.90%

Cronos Group Inc. Common Share

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.03

Actual

$0.04

Surprise

+17.65%

Collegium Pharmaceutical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.89

Actual

$1.96

Surprise

+3.17%

Ironwood Pharmaceuticals, Inc. - Class A

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.32

Actual

$0.36

Surprise

+9.16%

ARS Pharmaceuticals, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.32

Actual

-$0.36

Surprise

-11.15%

Profound Medical Corp. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.18

Actual

-$0.21

Surprise

-11.41%

Akebia Therapeutics, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.03

Actual

-$0.04

Surprise

-6.95%

FAQ

What were Quoin Pharmaceuticals, Ltd. - ADR's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.

How did the market react to Quoin Pharmaceuticals, Ltd. - ADR's Q3 2026 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Quoin Pharmaceuticals, Ltd. - ADR expected to report next?

The next earning report is scheduled for Mar 24, 2027.

What are the forecasts for Quoin Pharmaceuticals, Ltd. - ADR's next earnings report?

Based on -- analysts, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$1.51 and revenue of -- for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.